Prevalence of cytomegalovirus in nonrheumatic stenotic aortic valves

American Journal of Cardiology

Volumn 89, Issue 4, 2002, Pages 477-479

  Radke, Peter W ^a,c   Ortlepp, Jan R ^a   Merkelbach Bruse, Sabine ^b   Messmer, Bruno J ^b   Kaiser, Axel ^a   Kronenberger, Stephan ^d   Handt, Stefan ^b   Hanrath, Peter ^a  

^a Medical Clinic I   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; VIRUS DNA;

AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; GENOME; HUMAN; POLYMERASE CHAIN REACTION; PRESSURE GRADIENT; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY;

EID: 0037083234     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)02277-9     Document Type: Article

References (19)

1. Progression of valvular AS in adults: Literature review and clinical implications
2. Characterization of the early lesions of degenerative valvular aortic stenosis
3. Accumulation of T lymphocytes and expression of interleukin-2 receptors in non-rheumatic stenotic aortic valves
4. Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves
5. Role of infectious agents in atherosclerosis and restenosis: An asessment of the evidence and need for future research
6. High levels of cytomegalovirus in patients requiring vascular surgery for atherosclerosis
7. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis
8. Cytomegalivirus infection is associated with cardiac allograft rejection and atherosclerosis
9. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy
10. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis
11. Cytomegalovirus in calcific aortic stenosis
12. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts
13. Infectious agents in coronary lesions obtained by endatherectomy: Prevalence, distribution pattern, co-infection, and clinical findings
14. Novel enzyme immunoassay and optimized DNA extraction for the detection of polymerase-chain-reaction amplified viral DNA from paraffin-embedded tissue
15. Chronic infections and coronary heart disease: Is there a link?
16. Inflammation, infection, and cardiovascular risk. How good is the clinical evidence?
17. Randomized clinical trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study
18. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery
19. Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts